A focused newsletter on the FDA's decisions and calendar, for people whose product waits on it
When something happens
The US drug and device regulator's own decisions and calendar, as they happen: approvals and rejections, advisory committee meetings, new guidance and its comment periods, and warning letters. For people whose product waits on this agency.
Not consumer health advice aimed at patients, not stock price commentary, not other countries' regulators, except where they issue a joint decision, not unverified rumours before the agency confirms them.
Where the news comes from: FDA press announcements, The FDA newsroom, Endpoints News, The Regulatory Affairs Professionals Society, The FDA advisory committee calendar.
Nobody gets this one yet. It starts when you do.